Evidence map›Paper›PMID 29858670›Full record

ArticleJournal of materials science. Materials in medicine2018

Human amniotic membrane for guided bone regeneration of calvarial defects in mice.

Mathilde Fénelon, Olivier Chassande, Jérome Kalisky, Florelle Gindraux, Stéphanie Brun, Reine Bareille, Zoran Ivanovic, Jean-Christophe Fricain, Claudine Boiziau

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Human amniotic membrane application in oral surgery-AnFrontiers in bioengineering and biotechnology · 2022
    Article
  11. Article
  12. Advances in Barrier Membranes for Guided Bone Regeneration Techniques.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mathilde FénelonUniv. Bordeaux, INSERM, Laboratory BioTis, UMR 1026, F-33076, Bordeaux, France. mathilde.fenelon@u-bordeaux.fr.
Olivier ChassandeUniv. Bordeaux, INSERM, Laboratory BioTis, UMR 1026, F-33076, Bordeaux, France.
Jérome KaliskyUniv. Bordeaux, INSERM, Laboratory BioTis, UMR 1026, F-33076, Bordeaux, France.
Florelle GindrauxOrthopedic, Traumatologic & Plastic Surgery Service - University Hospital of Besançon, Besançon, France.
Stéphanie BrunUniversity hospital, Gynecology-Obstetrics Service, F-33076, Bordeaux, France.
Reine BareilleUniv. Bordeaux, INSERM, Laboratory BioTis, UMR 1026, F-33076, Bordeaux, France.
Zoran IvanovicFrench Blood Establishment (EFS), Aquitaine-Limousin Branch, Bordeaux, France.
Jean-Christophe FricainUniv. Bordeaux, INSERM, Laboratory BioTis, UMR 1026, F-33076, Bordeaux, France.
Claudine BoiziauUniv. Bordeaux, INSERM, Laboratory BioTis, UMR 1026, F-33076, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its biological properties, human amniotic membrane (hAM) is widely studied in the field of tissue engineering and regenerative medicine. hAM is already very attractive for wound healing and it may be helpful as a support for bone regeneration. However, few studies assessed its potential for guided bone regeneration (GBR). The purpose of the present study was to assess the potential of the hAM as a membrane for GBR. In vitro, cell viability in fresh and cryopreserved hAM was assessed. In vivo, we evaluated the impact of fresh versus cryopreserved hAM, using both the epithelial or the mesenchymal layer facing the defect, on bone regeneration in a critical calvarial bone defect in mice. Then, the efficacy of cryopreserved hAM associated with a bone substitute was compared to a collagen membrane currently used for GBR. In vitro, no statistical difference was observed between the conditions concerning cell viability. Without graft material, cryopreserved hAM induced more bone formation when the mesenchymal layer covered the defect compared to the defect left empty. When associated with a bone substitute, such improved bone repair was not observed. These preliminary results suggest that cryopreserved hAM has a limited potential for GBR.

Indexed as

Guided Tissue RegenerationAmnionAnimalsBiocompatible MaterialsBone and BonesBone RegenerationBone SubstitutesCell SurvivalCollagenCryopreservationDurapatiteFemaleHumansMiceMice, Inbred C57BLOsteogenesisBiocompatible MaterialsBone SubstitutesCollagenDurapatite

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.